Paul J. Clancy
2012
In 2012, Paul J. Clancy earned a total compensation of $3.7M as EVP, Chief Financial Officer at Biogen, a 25% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $18,702 |
|---|---|
| Non-Equity Incentive Plan | $607,941 |
| Salary | $635,820 |
| Stock Awards | $2,287,448 |
| Other | $141,584 |
| Total | $3,691,495 |
Clancy received $2.3M in stock awards, accounting for 62% of the total pay in 2012.
Clancy also received $18.7K of change in pension value and nonqualified deferred compensation earnings, $607.9K in non-equity incentive plan, $635.8K in salary and $141.6K in other compensation.
Rankings
In 2012, Paul J. Clancy's compensation ranked 1,829th out of 11,487 executives tracked by ExecPay. In other words, Clancy earned more than 84.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,829 out of 11,487 | 84th |
Division Manufacturing | 657 out of 4,253 | 85th |
Major group Chemicals And Allied Products | 149 out of 1,198 | 88th |
Industry group Drugs | 83 out of 920 | 91st |
Industry Biological Products, Except Diagnostic Substances | 13 out of 160 | 92nd |
Source: SEC filing on April 30, 2015.
Clancy's colleagues
We found four more compensation records of executives who worked with Paul J. Clancy at Biogen in 2012.